Anavex Life Sciences Statistics Share Statistics Anavex Life Sciences has 85.42M
shares outstanding. The number of shares has increased by 0.68%
in one year.
Shares Outstanding 85.42M Shares Change (YoY) 0.68% Shares Change (QoQ) 0.36% Owned by Institutions (%) 36.87% Shares Floating 82.56M Failed to Deliver (FTD) Shares 28,272 FTD / Avg. Volume 2.76%
Short Selling Information The latest short interest is 25.15M, so 29.44% of the outstanding
shares have been sold short.
Short Interest 25.15M Short % of Shares Out 29.44% Short % of Float 30.44% Short Ratio (days to cover) 25.3
Valuation Ratios The PE ratio is -11.03 and the forward
PE ratio is 7.85.
Anavex Life Sciences's PEG ratio is
0.83.
PE Ratio -11.03 Forward PE 7.85 PS Ratio 0 Forward PS 4.3 PB Ratio 3.94 P/FCF Ratio -15.39 PEG Ratio 0.83
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Anavex Life Sciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 8.86,
with a Debt / Equity ratio of 0.
Current Ratio 8.86 Quick Ratio 8.86 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.02M Employee Count 42 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -2.29M Effective Tax Rate 5.06%
Stock Price Statistics The stock price has increased by 84.09% in the
last 52 weeks. The beta is 0.8, so Anavex Life Sciences's
price volatility has been higher than the market average.
Beta 0.8 52-Week Price Change 84.09% 50-Day Moving Average 9.98 200-Day Moving Average 9.12 Relative Strength Index (RSI) 51.92 Average Volume (20 Days) 1,026,087
Income Statement
Revenue n/a Gross Profit n/a Operating Income -52.88M Net Income -43M EBITDA -45.29M EBIT -45.29M Earnings Per Share (EPS) -0.52
Full Income Statement Balance Sheet The company has 132.19M in cash and 0 in
debt, giving a net cash position of 132.19M.
Cash & Cash Equivalents 132.19M Total Debt n/a Net Cash n/a Retained Earnings -336.07M Total Assets 117.14M Working Capital 99.76M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -30.81M
and capital expenditures 0, giving a free cash flow of -30.81M.
Operating Cash Flow -30.81M Capital Expenditures n/a Free Cash Flow -30.81M FCF Per Share -0.37
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields AVXL does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for AVXL is $46,
which is 305.6% higher than the current price. The consensus rating is "Buy".
Price Target $46 Price Target Difference 305.6% Analyst Consensus Buy Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 7, 2015. It was a
backward
split with a ratio of 1:4.
Last Split Date Oct 7, 2015 Split Type backward Split Ratio 1:4
Scores Altman Z-Score 27.17 Piotroski F-Score 1
